Annual EBIT:
$9.14B+$663.00M(+7.82%)Summary
- As of today, ABBV annual earnings before interest & taxes is $9.14 billion, with the most recent change of +$663.00 million (+7.82%) on December 31, 2024.
- During the last 3 years, ABBV annual EBIT has fallen by -$6.28 billion (-40.72%).
- ABBV annual EBIT is now -41.83% below its all-time high of $15.71 billion, reached on December 31, 2022.
Performance
ABBV EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$4.89B-$909.00M(-15.67%)Summary
- As of today, ABBV quarterly earnings before interest & taxes is $4.89 billion, with the most recent change of -$909.00 million (-15.67%) on September 30, 2025.
- Over the past year, ABBV quarterly EBIT has increased by +$929.00 million (+23.45%).
- ABBV quarterly EBIT is now -19.65% below its all-time high of $6.09 billion, reached on December 31, 2022.
Performance
ABBV Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$19.37B+$929.00M(+5.04%)Summary
- As of today, ABBV TTM earnings before interest & taxes is $19.37 billion, with the most recent change of +$929.00 million (+5.04%) on September 30, 2025.
- Over the past year, ABBV TTM EBIT has increased by +$2.37 billion (+13.93%).
- ABBV TTM EBIT is now -16.88% below its all-time high of $23.30 billion, reached on March 31, 2023.
Performance
ABBV TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ABBV EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +7.8% | +23.4% | +13.9% |
| 3Y3 Years | -40.7% | -16.1% | -11.1% |
| 5Y5 Years | -10.5% | +38.4% | +42.3% |
ABBV EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -41.8% | +7.8% | -19.6% | +63.6% | -16.9% | +16.5% |
| 5Y | 5-Year | -41.8% | +56.1% | -19.6% | +63.6% | -16.9% | +42.3% |
| All-Time | All-Time | -41.8% | +226.6% | -19.6% | +7242.4% | -16.9% | +2025.0% |
ABBV EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $4.89B(-15.7%) | $19.37B(+5.0%) |
| Jun 2025 | - | $5.80B(+45.1%) | $18.44B(+4.6%) |
| Mar 2025 | - | $4.00B(-14.6%) | $17.63B(+6.1%) |
| Dec 2024 | $9.14B(+7.8%) | $4.68B(+18.1%) | $16.63B(-2.2%) |
| Sep 2024 | - | $3.96B(-20.7%) | $17.00B(-3.3%) |
| Jun 2024 | - | $4.99B(+67.1%) | $17.58B(+1.4%) |
| Mar 2024 | - | $2.99B(-40.9%) | $17.34B(-13.8%) |
| Dec 2023 | $8.47B(-46.0%) | $5.05B(+11.3%) | $20.12B(-4.9%) |
| Sep 2023 | - | $4.54B(-4.4%) | $21.15B(-5.7%) |
| Jun 2023 | - | $4.75B(-17.7%) | $22.44B(-3.7%) |
| Mar 2023 | - | $5.77B(-5.2%) | $23.30B(+3.3%) |
| Dec 2022 | $15.71B(+1.9%) | $6.09B(+4.4%) | $22.55B(+3.6%) |
| Sep 2022 | - | $5.83B(+3.8%) | $21.78B(+2.0%) |
| Jun 2022 | - | $5.61B(+11.8%) | $21.35B(+4.8%) |
| Mar 2022 | - | $5.02B(-5.5%) | $20.37B(+3.3%) |
| Dec 2021 | $15.41B(+163.4%) | $5.31B(-1.7%) | $19.71B(+4.2%) |
| Sep 2021 | - | $5.41B(+16.9%) | $18.91B(+11.0%) |
| Jun 2021 | - | $4.63B(+6.1%) | $17.04B(+10.7%) |
| Mar 2021 | - | $4.36B(-3.3%) | $15.39B(+5.1%) |
| Dec 2020 | $5.85B(-42.7%) | $4.51B(+27.6%) | $14.65B(+7.6%) |
| Sep 2020 | - | $3.54B(+18.5%) | $13.61B(-0.9%) |
| Jun 2020 | - | $2.98B(-17.6%) | $13.73B(-3.6%) |
| Mar 2020 | - | $3.62B(+4.2%) | $14.24B(+2.4%) |
| Dec 2019 | $10.21B(+56.0%) | $3.47B(-4.9%) | $13.91B(+3.5%) |
| Sep 2019 | - | $3.65B(+4.5%) | $13.44B(+2.8%) |
| Jun 2019 | - | $3.50B(+6.2%) | $13.08B(+5.6%) |
| Mar 2019 | - | $3.29B(+9.7%) | $12.39B(+1.1%) |
| Dec 2018 | $6.54B | $3.00B(-8.8%) | $12.26B(+4.4%) |
| Sep 2018 | - | $3.29B(+17.1%) | $11.74B(+5.6%) |
| Jun 2018 | - | $2.81B(-11.0%) | $11.11B(+0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $3.16B(+27.1%) | $11.05B(+7.2%) |
| Dec 2017 | $8.88B(-0.6%) | $2.48B(-6.8%) | $10.31B(+0.6%) |
| Sep 2017 | - | $2.66B(-3.1%) | $10.25B(+1.6%) |
| Jun 2017 | - | $2.75B(+13.6%) | $10.08B(+2.2%) |
| Mar 2017 | - | $2.42B(-0.1%) | $9.87B(+0.9%) |
| Dec 2016 | $8.93B(+21.3%) | $2.42B(-3.1%) | $9.78B(+2.4%) |
| Sep 2016 | - | $2.50B(-1.2%) | $9.55B(+6.2%) |
| Jun 2016 | - | $2.53B(+8.4%) | $8.99B(+3.2%) |
| Mar 2016 | - | $2.33B(+6.6%) | $8.71B(+5.3%) |
| Dec 2015 | $7.36B(+163.2%) | $2.19B(+13.0%) | $8.27B(+9.9%) |
| Sep 2015 | - | $1.94B(-13.9%) | $7.53B(+7.0%) |
| Jun 2015 | - | $2.25B(+18.7%) | $7.03B(+9.0%) |
| Mar 2015 | - | $1.90B(+31.4%) | $6.45B(+7.5%) |
| Dec 2014 | $2.80B(-50.3%) | $1.44B(-0.1%) | $6.00B(-4.0%) |
| Sep 2014 | - | $1.44B(-13.5%) | $6.25B(-3.3%) |
| Jun 2014 | - | $1.67B(+15.6%) | $6.46B(+0.4%) |
| Mar 2014 | - | $1.45B(-14.5%) | $6.44B(+1.5%) |
| Dec 2013 | $5.63B(-3.4%) | $1.69B(+2.1%) | $6.34B(-4.3%) |
| Sep 2013 | - | $1.66B(+0.5%) | $6.62B(-2.4%) |
| Jun 2013 | - | $1.65B(+22.2%) | $6.79B(+0.6%) |
| Mar 2013 | - | $1.35B(-31.6%) | $6.75B(+1.6%) |
| Dec 2012 | $5.83B(+58.9%) | $1.97B(+8.3%) | $6.64B(+2.1%) |
| Sep 2012 | - | $1.82B(+13.4%) | $6.50B(+36.9%) |
| Jun 2012 | - | $1.61B(+29.1%) | $4.75B(+1.4%) |
| Mar 2012 | - | $1.24B(-32.3%) | $4.69B(+7.6%) |
| Dec 2011 | $3.67B(-24.2%) | $1.83B(+2654.5%) | $4.35B(+72.8%) |
| Sep 2011 | - | $66.61M(-95.7%) | $2.52B(+2.7%) |
| Jun 2011 | - | $1.54B(+69.1%) | $2.45B(+169.1%) |
| Mar 2011 | - | $911.44M | $911.44M |
| Dec 2010 | $4.84B(-5.2%) | - | - |
| Dec 2009 | $5.10B | - | - |
FAQ
- What is AbbVie Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for AbbVie Inc.?
- What is AbbVie Inc. annual EBIT year-on-year change?
- What is AbbVie Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for AbbVie Inc.?
- What is AbbVie Inc. quarterly EBIT year-on-year change?
- What is AbbVie Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for AbbVie Inc.?
- What is AbbVie Inc. TTM EBIT year-on-year change?
What is AbbVie Inc. annual earnings before interest & taxes?
The current annual EBIT of ABBV is $9.14B
What is the all-time high annual EBIT for AbbVie Inc.?
AbbVie Inc. all-time high annual earnings before interest & taxes is $15.71B
What is AbbVie Inc. annual EBIT year-on-year change?
Over the past year, ABBV annual earnings before interest & taxes has changed by +$663.00M (+7.82%)
What is AbbVie Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of ABBV is $4.89B
What is the all-time high quarterly EBIT for AbbVie Inc.?
AbbVie Inc. all-time high quarterly earnings before interest & taxes is $6.09B
What is AbbVie Inc. quarterly EBIT year-on-year change?
Over the past year, ABBV quarterly earnings before interest & taxes has changed by +$929.00M (+23.45%)
What is AbbVie Inc. TTM earnings before interest & taxes?
The current TTM EBIT of ABBV is $19.37B
What is the all-time high TTM EBIT for AbbVie Inc.?
AbbVie Inc. all-time high TTM earnings before interest & taxes is $23.30B
What is AbbVie Inc. TTM EBIT year-on-year change?
Over the past year, ABBV TTM earnings before interest & taxes has changed by +$2.37B (+13.93%)